- ￥4520
- Sino Biological
- 北京
- 11705-V08H
- 2025年08月12日
企业认证
相关产品推荐更多 >
Influenza A H5N8 (A/duck/Zhejiang/6D18/2013) Hemagglutinin / HA1 Protein (His Tag)
￥4520
重组乙型流感 (B/Brisbane/60/2008) Hemagglutinin / HA 蛋白 (His Tag)
￥5170
重组新冠病毒Coronavirus spike（XBB.1.5）蛋白
￥4520
M1R Protein重组蛋白|Recombinant Monkeypox Virus (MPXV) M1R Protein (His Tag)
￥5820
SARS-CoV-2 Spike RBD (N354D) Protein (His Tag), Biotinylated
￥4520
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃ 至 -80℃
- 保质期：
12个月
- 英文名：
Influenza A H11N2 (A/duck/Yangzhou/906/2002) Hemagglutinin / HA Protein (His Tag)
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 规格：
100 µg
蛋白名称：Hemagglutinin/HA蛋白, Hemagglutinin/HA protein
蛋白构建：A DNA sequence encoding the extracellular domain (Met 1-Lys 528) of the influenza hemagglutinin (A/duck/Yangzhou/906/2002 (H11N2)) (AAY85533.1) (HA1+HA2, uncleaved), was fused with a C-terminal polyhistidine tag.
表达宿主：HEK293 Cells
蛋白纯度：> 97 % as determined by SDS-PAGE
蛋白活性：0
蛋白内毒素：< 1.0 EU per μg of the protein as determined by the LAL method
预测N端：Asp 17
蛋白分子量：The secreted recombinant influenza A H11N2 HA (A/duck/Yangzhou/906/2002 (H11N2)) comprises 523 amino acids and has a predicted molecular mass of 59 kDa. As a result of glycosylation, it migrates as an approximately 70 kDa band in SDS-PAGE under reducing conditions.
蛋白NP号：AAY85533.1
蛋白氨基酸序列：Met1-Lys528
蛋白标签：C-His
蛋白保存条件：Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PCR for the Detection of Influenza Viruses in Clinical Material
). Influenza A viruses are further divided into subtypes H1N1, H2N2 and H3N2, based on differences in the hemagglutinin (HA) and neuraminidase (NA) genes. The ability of influenza viruses to undergo antigenic change in HA and NA enables the virus to evade
Genetic Engineering of Live Attenuated Influenza Viruses
The first live attenuated influenza vaccine (LAIV) was licensed in the USA in 2003; it is a trivalent vaccine composed of two type A (H1N1 and H3N2) and one type B influenza virus each at 107 fluorescent focus units (FFU). Each influenza
Preparation and Analysis of Glycan Microarrays
2‐3‐linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin. J. Virol. 81:8341‐8345. Blixt, O., Head, S., Mondala, T., Scanlan, C., Huflejt
技术资料暂无技术资料 索取技术资料
